Intravenous (IV) drug administation is a common procedure requiring venous cannulation. Despite its prevalence, IV therapy has several associated risks, such as infection, phelbitis, hypervolaemia and anaphylaxis. This article provides a brief overview of current clinical guidance on IV therapy and the current challenges in terms of infection control and ensuring patient safety.
|Number of pages||5|
|Journal||British Journal of Healthcare Management|
|Publication status||Published - 2015|
- Clinical guidance
- Infection prevention
- Intravenous therapy
- Patient safety